Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News CohBar Inc CWBR

Healthcare Biotechnology
CohBar, Inc. is a clinical-stage biotechnology company. The Company is focused on developing therapeutics targeting chronic and age-related diseases. Its processes of identifying nucleic acid sequences encoding native peptides in the mitochondrial genome, developing and optimizing novel analogs of these natural mitochondrial derived peptides (MDPs) and developing and conducting screens to... see more

Recent & Breaking News (GREY:CWBR)

CohBar, Inc. Completes US$5.2 Million Private Placement

GlobeNewswire July 17, 2017

CohBar, Inc. Announces Private Placement Offering

GlobeNewswire June 23, 2017

CohBar, Inc. to Hold 2017 Annual Shareholder Meeting and Investor Update June 15, 2017

GlobeNewswire June 1, 2017

CohBar, Inc. Announces First Quarter 2017 Financial Results

GlobeNewswire May 15, 2017

CohBar, Inc.’s CEO Simon Allen to Present at the 1st Annual H.C. Wainwright & Co. NASH Investor Conference in New York

Business Wire March 29, 2017

CohBar, Inc. Announces Fourth Quarter 2016 Financial Results

Business Wire March 22, 2017

CohBar, Inc. to Announce Fourth Quarter 2016 Financial Results and Host Conference Call for Shareholders on March 22, 2017

Business Wire March 3, 2017

CohBar, Inc. Announces Positive Results from Preclinical NASH Study of its Lead Drug Candidates

Business Wire February 21, 2017

CohBar, Inc.’s CEO Simon Allen to Present at the 2017 BIO CEO & Investor Conference in New York

Business Wire February 9, 2017

CohBar Inc. Presentation Now Available for On-Demand Viewing

PR Newswire February 6, 2017

CohBar Inc. to Webcast, Live, at VirtualInvestorConferences.com February 2

PR Newswire February 1, 2017

Life Sciences & Healthcare Investor Conference & Webinar: Nasdaq and OTCQX Companies Present February 2nd

PR Newswire January 30, 2017

CohBar, Inc. Announces Expiration of Warrants and Reports Aggregate Proceeds from Warrant Exercises

Business Wire January 11, 2017

CohBar, Inc.’s CEO Simon Allen to Present at the 9th Annual Biotech Showcase in San Francisco

Business Wire January 10, 2017

CohBar, Inc. Continues Exploration of Mitochondrial Genome and Expansion of Its IP Portfolio with Filing of 29 New Provisional Patents

Business Wire December 6, 2016

CohBar, Inc. Announces Third Quarter 2016 Financial Results

Business Wire November 14, 2016

CohBar, Inc.’s CEO Simon Allen to Present at BIO Investor Forum 2016

Business Wire October 18, 2016

CohBar, Inc. Announces Discovery of New Peptides in the Mitochondrial Genome

Business Wire October 13, 2016

CohBar Advances First-in-Class Mitochondria Based Therapeutic to IND-Enabling Activities

Business Wire September 30, 2016

VIDEO: CohBar, Inc. CEO Simon Allen Interviewed for OTCQX Video Series

PR Newswire August 29, 2016